Inquire Before Buying - China Injectable Drug Delivery Devices Market Insights 2032

China Injectable Drug Delivery Devices Market Research Report: Forecast (2026–2032)

By Product (Conventional Syringes, Safety Syringes, Prefilled Syringes, Auto Injectors, Pen Injectors, Needle-Free Injectors, Wearable Injectors, Others), By Therapeutic Applicatio......n (Diabetes, Autoimmune Diseases, Obesity, Oncology, Hormonal Disorders, Infectious Diseases, Rare Diseases, Others), By Formulation Packaging (Ampoules, Vials, Cartridges, Prefilled Syringes, Dual-Chamber Systems), By Usage Pattern (Curative Care, Immunization, Other Usage Patterns), By Route of Administration (Dermal-Based Administration, Circulatory/Musculoskeletal System-Based Administration, Organ-Based Administration, Central Nervous System (CNS)-Based Administration), By End User (Hospitals & Clinics, Home Care Settings, Long-Term Care Settings, Nursing Homes, Other End Users), and others Read more

Healthcare
Jun 2026
Pages 119
Report Format: PDF, Excel, PPT

China Injectable Drug Delivery Devices Market Report Takeaways

The China Injectable Drug Delivery Devices Market was valued at USD 4.87 billion in 2025, reached USD 6.67 billion in 2026, and is projected to attain USD 8.35 billion by 2032.
The industry is projected to witness steady CAGR of 3.81% during the forecast period i.e., 2026-32.
By product, Conventional Syringes emerged as the leading segment, accounting for approximately 32% market share in 2026.
By therapeutic application, Diabetes dominated the market with an estimated 72% share in 2026.
The market is moderately consolidated, with leading companies collectively accounting for approximately 30% of total market revenue.

China Injectable Drug Delivery Devices Market Size and Outlook

The China Injectable Drug Delivery Devices Market was valued at USD 4.87 billion in 2025, to USD 6.67 billion, and is projected to reach USD 8.35 billion by 2033, expanding at a CAGR of 3.81%. This growth is anchored in the country's exceptionally high chronic disease burden.

According to the International Diabetes Federation's (IDF) 11th Edition Diabetes Atlas (2025), approximately 13.8% of Chinese adults aged 20–79 years are living with diabetes, with diabetes-related healthcare expenditure exceeding USD 168 billion annually. The growing diabetic population is driving substantial demand for injectable therapies, including insulin and GLP-1 receptor agonists, which rely on advanced drug delivery devices such as prefilled syringes, autoinjectors, pen injectors, and other parenteral administration systems.

As the prevalence of diabetes continues to rise, the need for convenient, accurate, and patient-friendly drug delivery solutions is expected to increase, supporting sustained growth in the market for injectable drug delivery devices across China. Furthermore, according to the Chinese Medical Journal, an estimated 3.25 million new cancer cases were recorded in China in 2024, the highest in the world, creating an expanding patient base requiring injectable oncology biologics and chemotherapy delivery devices across hospital and ambulatory settings.

The National Healthcare Security Administration's (NHSA) December 2024 update to the National Reimbursement Drug List (NRDL), effective January 1, 2025, added 91 new drugs of which 38 were classified as globally novel innovative drugs with oncology and chronic disease therapies accounting for the majority of additions. An estimated patient cost saving of over USD 6.95 billion was projected for 2025 as a result, substantially reducing financial barriers to injectable therapy access and accelerating device utilization across institutional end-users including hospitals, specialty treatment centers, and community health clinics.

Additionally, the State Council's Full-Chain Support for Biopharmaceutical Innovation policy, issued in July 2024, established a national framework spanning drug approval, insurance reimbursement, and commercialization directly stimulating domestic production of injectable biologics and, in turn, demand for compatible drug-device combination products.

Furthermore, the NMPA's NMPA-No86-2025 directive established a 30-working-day clinical trial approval channel for innovative drugs, further shortening the pipeline-to-market timeline for new injectable biologics, a regulatory catalyst expected to sustain device demand through the forecast period. Collectively, structural disease prevalence, expanding reimbursement coverage, a pro-innovation regulatory environment, and an aging institutional patient base position the sector for compounding growth well beyond current projections.

China Injectable Drug Delivery Devices Market Key Indicators

According to the National Bureau of Statistics of China, by end-2025 China had 1.107 million medical and health institutions including 38,000 hospitals with 7.99 million inpatient beds generating an immense and continuous institutional demand for sterile injectable drug delivery devices across surgical, oncology, and critical care wards.
China's National Health Commission reported that total national health expenditure reached approximately USD 1.26 trillion in 2024, equivalent to 6.7% of GDP, with per capita health expenditure reaching USD 952.84 a financing base that directly supports expanded procurement of prefilled syringes, autoinjectors, and pen injectors across public and private hospital systems.
The World Health Organization confirmed that China launched a national HPV vaccination programme on November 10, 2025, targeting all girls born on or after November 10, 2011 who have reached age 13 a program requiring two-dose bivalent HPV injectable administration at scale across the national immunization infrastructure, generating immediate and recurring demand for vaccine delivery systems and disposable injectable devices.

China Injectable Drug Delivery Devices Market Scope

Category	Segments
By Product	Conventional Syringes, Safety Syringes, Prefilled Syringes, Auto Injectors, Pen Injectors, Needle-Free Injectors, Wearable Injectors, Others
By Therapeutic Application	Diabetes, Autoimmune Diseases, Obesity, Oncology, Hormonal Disorders, Infectious Diseases, Rare Diseases, Others
By Formulation Packaging	Ampoules, Vials, Cartridges, Prefilled Syringes, Dual-Chamber Systems
By Usage Pattern	Curative Care, Immunization, Other Usage Patterns
By Route of Administration	Dermal-Based Administration, Circulatory/Musculoskeletal System-Based Administration, Organ-Based Administration, Central Nervous System (CNS)-Based Administration
By End User	Hospitals & Clinics, Home Care Settings, Long-Term Care Settings, Nursing Homes, Other End Users

China Injectable Drug Delivery Devices Industry Growth Drivers

Surging Biologics and Biosimilars Pipeline Driving Demand for Specialized Injectable Drug Delivery Devices in China

China's growing biologics and biosimilars pipeline is the primary structural force creating demand for injectable drug delivery devices. Biologics including monoclonal antibodies, biosimilar therapies, and antibody-drug conjugates (ADCs) cannot be administered orally due to enzymatic degradation and require prefilled syringes, autoinjectors, or pen injectors for delivery, creating a direct volume relationship between approvals and device consumption.

According to a study published in PMC (2025) using NMPA data, China approved 161 new drugs between 2019 and 2023 the highest count globally, surpassing the United States (243), the European Union (191), and Japan (187). The majority of which are biologic or injectable therapeutics requiring compatible delivery systems.

Furthermore, China's innovative drug license-out transactions reached USD 51.9 billion in 2024, a 27.4% year-on-year increase, capturing nearly one-third of the global total, with monoclonal antibody licensing alone rising 43% to USD 11.3 billion, each licensed molecule entering late-stage development requiring a validated injectable delivery device meeting international standard.

This expanding injectable biologics delivery pipeline positions device manufacturers supplying high-viscosity-compatible drug-device combination products as direct beneficiaries of China's biopharma growth trajectory.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
China Injectable Drug Delivery Devices Market Policies, Regulations, and Product Standards
China Injectable Drug Delivery Devices Market Trends & Developments
China Injectable Drug Delivery Devices Market Dynamics
1. Growth Factors
2. Challenges
China Injectable Drug Delivery Devices Market Hotspot & Opportunities
China Injectable Drug Delivery Devices Market Outlook, 2022-2032F
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Product- Market Size & Forecast 2022-2032, USD Million
    1. Conventional Syringes
    2. Safety Syringes
    3. Prefilled Syringes
    4. Auto Injectors
    5. Pen Injectors
    6. Needle-Free Injectors
    7. Wearable Injectors
    8. Others
  2. By Therapeutic Application- Market Size & Forecast 2022-2032, USD Million
    1. Diabetes
    2. Autoimmune Diseases
    3. Obesity
    4. Oncology
    5. Hormonal Disorders
    6. Infectious Diseases
    7. Rare Diseases
    8. Others
  3. By Formulation Packaging- Market Size & Forecast 2022-2032, USD Million
    1. Ampoules
    2. Vials
    3. Cartridges
    4. Prefilled Syringes
    5. Dual-Chamber Systems
  4. By Usage Pattern- Market Size & Forecast 2022-2032, USD Million
    1. Curative Care
    2. Immunization
    3. Other Usage Patterns
  5. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
    1. Dermal-Based Administration
    2. Circulatory/Musculoskeletal System-Based Administration
    3. Organ-Based Administration
    4. Central Nervous System (CNS)-Based Administration
  6. By End User- Market Size & Forecast 2022-2032, USD Million
    1. Hospitals & Clinics
    2. Home Care Settings
    3. Long-Term Care Settings
    4. Nursing Homes
    5. Other End Users
  7. By Region- Market Size & Forecast 2022-2032, USD Million
    1. North
    2. South
    3. East
    4. West
    5. Central
  8. By Company
    1. Competition Characteristics
    2. Market Share & Analysis
China Conventional Syringes Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapeutic Application- Market Size & Forecast 2022-2032, USD Million
  2. By Formulation Packaging- Market Size & Forecast 2022-2032, USD Million
  3. By Usage Pattern- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By End User- Market Size & Forecast 2022-2032, USD Million
  6. By Region- Market Size & Forecast 2022-2032, USD Million
China Safety Syringes Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapeutic Application- Market Size & Forecast 2022-2032, USD Million
  2. By Formulation Packaging- Market Size & Forecast 2022-2032, USD Million
  3. By Usage Pattern- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By End User- Market Size & Forecast 2022-2032, USD Million
  6. By Region- Market Size & Forecast 2022-2032, USD Million
China Prefilled Syringes Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapeutic Application- Market Size & Forecast 2022-2032, USD Million
  2. By Formulation Packaging- Market Size & Forecast 2022-2032, USD Million
  3. By Usage Pattern- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By End User- Market Size & Forecast 2022-2032, USD Million
  6. By Region- Market Size & Forecast 2022-2032, USD Million
China Auto Injectors Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapeutic Application- Market Size & Forecast 2022-2032, USD Million
  2. By Formulation Packaging- Market Size & Forecast 2022-2032, USD Million
  3. By Usage Pattern- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By End User- Market Size & Forecast 2022-2032, USD Million
  6. By Region- Market Size & Forecast 2022-2032, USD Million
China Pen Injectors Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapeutic Application- Market Size & Forecast 2022-2032, USD Million
  2. By Formulation Packaging- Market Size & Forecast 2022-2032, USD Million
  3. By Usage Pattern- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By End User- Market Size & Forecast 2022-2032, USD Million
  6. By Region- Market Size & Forecast 2022-2032, USD Million
China Needle-Free Injectors Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapeutic Application- Market Size & Forecast 2022-2032, USD Million
  2. By Formulation Packaging- Market Size & Forecast 2022-2032, USD Million
  3. By Usage Pattern- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By End User- Market Size & Forecast 2022-2032, USD Million
  6. By Region- Market Size & Forecast 2022-2032, USD Million
China Wearable Injectors Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapeutic Application- Market Size & Forecast 2022-2032, USD Million
  2. By Formulation Packaging- Market Size & Forecast 2022-2032, USD Million
  3. By Usage Pattern- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By End User- Market Size & Forecast 2022-2032, USD Million
  6. By Region- Market Size & Forecast 2022-2032, USD Million
China Others Market Outlook, 2022-2032
1. Market Size & Outlook
  1. By Revenues (USD Million)
2. Market Share & Outlook
  1. By Therapeutic Application- Market Size & Forecast 2022-2032, USD Million
  2. By Formulation Packaging- Market Size & Forecast 2022-2032, USD Million
  3. By Usage Pattern- Market Size & Forecast 2022-2032, USD Million
  4. By Route of Administration- Market Size & Forecast 2022-2032, USD Million
  5. By End User- Market Size & Forecast 2022-2032, USD Million
  6. By Region- Market Size & Forecast 2022-2032, USD Million
China Injectable Drug Delivery Devices Market Key Strategic Imperatives for Success & Growth
Competitive Outlook
1. Company Profiles
  1. Becton, Dickinson and Company (BD)
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Baxter International Inc.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  3. B. Braun SE
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Terumo Corporation
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Cardinal Health, Inc.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Ypsomed Holding AG
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  7. West Pharmaceutical Services, Inc.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Gerresheimer AG
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Stevanato Group S.p.A.
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  10. SCHOTT Pharma AG & Co. KGaA
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  11. SHL Medical
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Owen Mumford
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Nemera
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
  14. Haselmeier
    1. Business Description
    2. Product Portfolio
    3. Collaborations & Alliances
    4. Recent Developments
    5. Financial Details
    6. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *